Skip to main content
. Author manuscript; available in PMC: 2021 Dec 10.
Published in final edited form as: J Clin Rheumatol. 2020 Jun;26(4):147–156. doi: 10.1097/RHU.0000000000001004

Table 2.

Study completion rates, overall and by treatment allocation

All subjects (N=84) Cherry extract (n=41) Diet modification (n=43)

Physician office communication
 Gout diagnosis confirmation 100% 100% 100%
 ACR gout classification criteria 94% 93% 95%
Internet study visits with survey assessments
 Baseline assessment 100% 100% 100%
 3-month assessment 93% 100% 86%
 6-month assessment 81% 90% 72%
 9-month assessment 69% 78% 60%
Serum urate blood draw testing1
 Baseline 100% 100% 100%
 9-month 77% 83% 72%
 2-weekly Gout flare assessment2 75% 82% 69%
Telephone support sessions for diet modification (Dietitian)
 Baseline -- -- 83%
 6-month -- -- 87%
 9-month -- -- 86%
Telephone support sessions for cherry extract adherence (study coordinator)
 Baseline -- 97% --
 1-month -- 90% --
 4-month -- 81% --

All study procedures and visits were completed over the Internet by participants in the comfort of their homes, or on the phone

1

Serum urate blood draw was done at the Quest Laboratory site closest to the patient residence or by patient choice, and results were reported directly to the study team in a HIPAA-compliant method

2

Two- weekly Gout flare assessments were done via the Internet; non-responders received a follow-up phone call to complete the brief questionnaire on the phone lasting <2 minutes